Products

Below is a list of the treatments we currently offer via our Innovative Medicines Division. 
Please note: Not all treatments are available in all countries.

Product Information

Chronic myeloid leukemia (Ph+ CML), Ph+ CML in blast crisis, Lymphoblastic leukemia (Ph+ ALL),MDS/MPD,SM,HES,CEL,CD117,GIST,Kit+ GIST, DFSP Protein-tyrosine kinase inhibitor

Active Ingredients - Imatinib

Product Division - Novartis Pharmaceuticals